Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 151.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	12.1	3.6	4.3	7.0	7.1	6.8	14.5	3.8	5.7	3.4	6.0	13.5	4.1	15.9	7.4	6.5	3.0	6.9	25.1	7.5	6.4	8.4	7.9	9.2	12.4	7.5	4.7	8.2	5.6	8.2	4.9	4.7	3.9	4.8	5.3	5.6	15.2	1.1	3.5	3.8	9.6	2.6	6.8	5.4	4.6	0.0	1.4	0.8	10.3	16.4	10.7	7.4	11.1	10.7	6.0	8.4	7.7	5.5	5.4	4.1	5.9	5.5	3.7	4.5	3.6	18.4	7.2	2.2	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2	20.8	23.2	15.3	15.5	9.4	36.9	94.9	20.4	29.4	29.6	15.7	51.1	77.6	19.9	11.9	1.1	10.8	15.8	23.3	11.2	17.2	13.6	9.9	10.4	84.7	15.8	49.3	16.1	16.0	16.2	1.1	9.5	9.2	15.1	10.8	18.2	151.6	14.2	10.5	20.1	16.3	47.8	6.5	14.2	8.1	11.7	8.2	24.4	15.0	17.4	16.6
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell type enriched"	"Detected in some"	11	"Ciliated cells: 38.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;SH-SY5Y: 2.4"									"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		68000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7											3.0	2.1	0.0	0.8	0.6	0.0	2.4	0.0	38.8	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 34.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.2	0.0	0.1	0.2	0.0	0.7	0.0	34.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 33.4;Ciliated cells: 95.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.7"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											3.0	33.4	0.0	0.0	0.0	0.0	0.4	0.0	95.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell type enriched"	"Detected in some"	68	"Exocrine glandular cells: 849.6"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.3"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		77000000			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	849.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 31.4;Exocrine glandular cells: 124.1"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.5;EFO-21: 11.8;HSkMC: 7.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		75000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.3	0.0	6.4	11.5	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.8	0.3	0.0	1.4	0.1	1.4	1.6	1.4	1.8	2.1	4.4	0.9	1.0	2.6	2.8	7.8	7.7	0.8	1.3	2.0	0.2	3.3	0.0	3.5	0.9	0.0	2.1	0.5	0.1	0.1	1.6	0.6	0.0	5.1	6.6	2.1	3.2	0.6	2.7	1.3	0.8	2.1	0.1	1.5	0.9	0.4	1.0	0.5	0.7	4.0	0.1	0.3	2.2	2.0	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8	11.9	16.1	3.2	2.8	4.1	10.0	6.9	5.1	17.4	18.2	1.8	31.4	0.3	0.0	0.7	4.8	1.5	3.6	0.0	124.1	0.2	1.4	1.2	3.5	5.9	1.5	9.5	4.7	1.8	7.0	2.3	2.3	3.1	5.0	1.8	2.5	2.4	1.3	1.4	1.8	0.4	16.2	0.0	2.2	1.7	0.6	2.6	0.2	0.8	2.5	0.9
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359500-42412318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6;skeletal muscle: 210.9"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 403.1;Late spermatids: 111.1;Melanocytes: 457.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	23	"SK-MEL-30: 77.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040052	Enhanced					NA	NA					"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	5.7	1.8	13.0	2.3	32.1	16.7	3.8	3.1	22.9	2.1	2.4	65.6	0.0	2.2	3.1	47.0	4.2	2.5	3.0	3.6	19.9	11.5	22.1	6.3	6.7	3.4	50.7	19.5	3.1	1.4	3.4	1.7	2.0	39.0	3.0	3.2	5.0	3.1	3.1	210.9	19.7	2.3	2.8	52.6	3.3	2.1	4.1	47.3	0.0	1.6	27.6	3.0	2.7	2.3	1.5	1.7	0.9	2.6	1.3	3.2	1.4	0.1	0.2	0.2	0.3	3.3	3.2	0.3	1.2	0.7	0.1	0.2	0.3	0.2	0.0	0.4	0.6	0.1	1.8	0.1	1.3	0.1	0.3	0.3	0.2	0.5	1.0	0.1	0.5	0.6	2.1	2.0	0.2	0.5	0.7	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.5	0.0	0.7	0.8	0.5	0.0	0.0	0.0	0.1	77.0	0.3	0.0	1.8	0.3	0.0	0.1	1.6	0.2	0.4	0.7	0.0	0.2	0.9	0.7	0.0	2.6	0.0	2.8	0.6	2.8	0.4	0.3	1.0	1.7	1.5	0.2	3.2	0.9	1.3	0.2	1.6	1.3	1.4	13.0	32.1	3.1	22.9	19.9	11.5	50.7	19.5	39.0	47.3	11.9	34.6	0.0	0.8	17.9	1.5	0.3	0.0	0.0	5.7	1.8	2.0	0.5	1.7	0.0	403.1	0.7	1.6	0.0	0.0	0.4	0.8	0.6	1.1	6.6	24.8	0.0	0.0	2.5	4.5	111.1	4.9	4.6	457.2	1.0	1.8	3.6	0.0	4.5	3.2	36.6	3.7	0.0	0.8	9.4	4.9	7.4	2.7	1.9	1.9	0.7
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119879	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7"	"Group enriched"	"Detected in all"	9	"dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3000000	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	27.5	19.6	13.8	17.0	14.8	11.3	18.6	14.3	23.0	14.9	16.5	23.4	21.7	19.4	20.1	50.9	13.9	18.2	23.5	21.4	13.5	17.6	27.9	44.2	34.0	30.2	18.1	16.1	14.6	29.4	28.8	24.7	84.1	14.9	22.3	7.2	21.9	27.5	22.1	26.3	18.3	15.4	17.2	16.6	35.8	17.4	30.7	14.6	13.9	21.9	14.9	13.5	24.0	13.4	1.4	15.6	10.8	24.7	1.1	1.8	9.8	11.4	22.4	4.4	14.5	13.9	14.0	28.9	7.2	13.3	5.5	4.5	6.6	18.7	4.1	19.2	5.6	4.7	4.9	1.4	8.3	1.3	5.3	16.7	0.0	3.8	23.7	24.2	0.5	13.7	30.1	12.0	10.3	3.6	11.2	9.7	11.2	4.1	17.3	4.1	26.5	1.9	2.7	9.2	2.8	15.7	10.0	15.2	7.0	4.4	12.0	5.1	14.7	9.4	10.5	12.9	2.8	30.0	16.4	6.2	20.4	11.0	14.7	2.6	41.4	11.5	1.2	6.5	10.7	12.8	0.1	23.8	8.4	1.5	20.0	1.8	1.3	1.2	1.6	15.6	1.4	1.4	0.9	10.8	1.1	24.7	3.8	0.8	9.8	13.8	14.8	14.3	23.0	13.5	17.6	18.1	16.1	14.9	14.6	17.9	45.3	3.9	14.4	10.0	15.6	14.3	30.6	5.3	17.0	14.0	7.9	106.8	5.0	23.0	42.5	17.4	18.6	0.0	13.8	125.7	30.3	19.9	8.1	23.1	92.2	11.1	5.8	29.4	107.0	25.5	22.2	64.5	23.6	31.5	14.3	28.7	9.4	17.5	18.0	18.2	16.5	6.5	10.3	18.4	26.8	7.3	139.0	7.7	15.5	10.8
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	13.3	14.0	12.5	17.3	20.7	17.6	14.4	16.6	14.2	15.8	14.3	25.6	15.4	11.7	17.9	26.0	20.7	12.9	13.0	12.4	13.4	10.4	13.5	18.0	30.5	13.8	25.0	13.7	18.8	13.1	17.4	20.5	10.8	19.8	13.1	17.8	18.3	20.4	13.7	23.9	13.9	15.4	15.9	25.1	15.5	13.1	24.5	22.6	17.4	16.8	12.3	18.3	16.2	16.3	17.6	12.2	9.3	10.1	4.0	7.4	4.7	6.2	3.2	7.9	8.6	9.6	13.6	5.0	13.7	14.8	15.1	12.7	4.7	4.4	3.4	7.5	13.8	10.5	13.0	9.5	14.6	10.5	8.5	4.4	8.5	8.6	9.2	8.1	8.2	7.4	9.2	8.7	6.1	10.5	8.5	10.2	8.7	8.8	9.6	11.9	1.3	5.5	9.1	4.9	2.7	4.2	10.6	9.3	11.8	11.4	5.8	6.0	8.5	7.7	6.7	4.8	4.5	2.5	19.4	9.2	15.9	4.2	13.1	8.2	10.4	13.7	6.9	7.5	15.1	8.7	9.3	9.3	7.4	3.7	10.1	5.0	16.2	5.7	6.9	12.2	17.6	7.4	4.4	5.0	4.0	8.1	9.6	5.5	4.7	12.5	20.7	16.6	14.2	13.4	10.4	25.0	13.7	19.8	22.6	17.9	36.3	8.3	15.1	9.3	5.1	6.9	2.5	12.0	10.3	1.8	9.8	4.4	5.0	4.3	9.0	4.0	8.4	0.0	3.3	4.2	4.5	6.5	10.4	9.0	6.0	3.2	4.1	7.4	11.6	3.0	6.6	10.3	13.5	11.8	5.5	10.4	5.0	16.5	6.0	6.3	6.5	12.9	5.2	14.2	14.4	4.5	2.4	5.0	7.5	21.3
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		5900000	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.1	7.3	2.4	34.9	61.4	46.7	4.4	20.2	28.8	12.1	20.6	1.4	3.2	13.6	8.9	24.8	7.2	1.4	2.0	9.3	28.6	6.4	1.1	4.2	15.2	4.5	42.3	14.3	3.7	34.4	6.9	19.5	20.1	30.5	26.9	1.6	3.3	7.9	39.4	3.5	2.4	17.0	2.4	3.4	11.2	4.5	11.1	16.0	8.6	4.1	1.2	1.6	13.2	3.8	4.1	3.7	2.7	11.8	37.3	25.1	5.9	17.6	18.6	36.1	4.1	5.0	40.9	9.6	10.2	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1	14.9	11.3	7.2	17.9	27.2	15.9	51.9	15.3	13.4	10.3	29.6	0.0	25.8	34.9	29.0	29.2	28.5	9.6	0.0	21.8	58.4	22.2	15.3	42.7	67.1	23.2	28.6	21.2	14.1	14.5	11.6	16.1	15.1	23.6	12.6	6.9	9.6	34.4	6.8	12.4	46.6	16.8	32.3	41.6	6.5	5.1	18.6	45.9	10.0	7.3	12.4
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.8	12.2	9.1	10.2	25.3	26.5	12.4	27.8	23.2	40.6	38.1	15.9	19.3	0.0	13.8	32.2	21.7	5.8	23.9	12.3	41.1	6.3	10.3	14.4	5.8	18.0	22.9	14.6	21.8	14.5	20.1	13.4	17.0	21.2	23.3	9.5	8.8	34.3	23.3	33.2	2.8	11.7	10.9	14.6	10.0	8.0	13.8	27.0	11.2	17.7	7.5	3.5	14.7	20.3	15.8	9.0	20.1	15.6	19.3	20.8	6.2	14.9	20.3	31.2	17.3	13.4	17.6	22.6	6.7	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4	11.9	12.0	15.2	20.5	10.8	7.4	202.8	10.2	16.0	11.4	31.4	17.7	31.4	23.2	37.5	172.2	32.3	12.4	0.0	67.2	38.6	32.6	36.2	17.4	13.9	84.7	6.4	13.8	43.0	102.9	292.0	49.2	51.1	38.8	27.9	13.4	81.1	32.6	13.3	72.2	12.2	4.9	64.7	60.5	46.6	19.8	13.0	24.5	62.3	12.1	16.9
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 15.8;Intestinal endocrine cells: 19.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.2	17.1	0.0	10.2	0.0	12.4	0.5	3.0	3.0	3.8	12.7	0.3	0.0	1.4	2.1	3.1	0.0	9.6	0.2	2.9	0.1	2.7	0.0	0.2	13.7	3.0	0.0	4.2	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.8	0.0	0.4	16.9	0.1	0.0	2.8	5.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	36.5	27.1	1.6	10.4	0.0	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1	0.0	0.0	0.0	0.9	0.3	0.9	0.6	2.5	0.0	0.0	0.0	3.9	5.3	5.0	0.8	0.3	0.0	0.2	0.0	3.4	7.0	1.9	1.7	0.0	15.8	0.9	0.0	19.5	0.0	1.3	0.0	0.6	0.0	3.3	0.0	1.3	1.8	2.8	0.0	2.8	2.1	0.0	0.0	0.9	0.3	0.4	0.3	1.9	0.0	2.0	0.5
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA		10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.7	11.5	8.5	11.7	19.9	7.8	16.9	20.0	14.1	21.1	24.7	11.2	9.4	12.0	12.2	19.5	5.6	20.6	14.2	25.4	18.5	7.4	20.6	9.9	14.7	9.9	11.2	10.8	7.4	19.2	12.2	13.5	11.5	18.3	17.6	12.7	6.9	16.1	26.4	10.9	13.4	9.4	4.5	12.5	13.2	11.4	14.9	11.8	20.9	30.9	5.3	7.4	17.8	23.3	4.7	11.9	12.3	11.3	13.6	25.9	10.0	11.6	21.6	13.3	13.8	5.9	26.4	9.5	5.8	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5	0.0	13.9	2.2	3.1	4.5	2.2	62.1	5.1	6.7	3.4	0.0	15.7	7.4	0.0	6.9	0.2	5.4	9.5	0.0	5.9	22.2	4.6	4.3	4.6	4.4	7.1	0.0	6.9	9.8	6.5	0.7	4.9	3.8	6.8	8.2	11.8	2.7	8.9	10.4	5.3	4.8	11.1	0.0	7.6	1.7	3.1	3.6	3.3	4.4	9.8	3.1
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536189-21604847	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 75.1"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 57.8"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;HEL: 1.9;SuSa: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039482	Approved					NA	NA					"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	75.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	2.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.2	0.6	1.9	0.2	0.0	0.3	0.5	0.4	0.5	0.2	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.6	0.0	0.3	0.3	0.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYZL1	"LYC2, MGC33408"	ENSG00000120563	"Lysozyme like 1"	Q6UWQ5	10	29289061-29318328	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	371	"testis: 39.5"	"Group enriched"	"Detected in some"	48	"Early spermatids: 474.4;Late spermatids: 148.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;SuSa: 2.9"														"Secreted in male reproductive system"	NA	NA												"unprognostic (1.88e-1)"						"unprognostic (8.40e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	474.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	4.2	1.9	0.0	0.0	0.0	0.0	0.0
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 54.5;U-266/70: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	2.1	2.3	4.4	4.8	1.8	1.6	3.3	1.7	1.4	1.0	0.8	2.0	6.1	0.0	2.2	2.0	2.1	1.3	0.3	0.7	0.1	5.2	1.6	1.0	1.5	2.6	2.2	0.1	9.4	5.9	0.6	0.3	0.3	3.7	3.3	54.5	4.0	6.5	0.5	3.1	8.9	4.7	3.4	0.7	0.3	8.5	0.8	3.0	2.3	0.7	0.0	1.0	0.6	3.2	2.9	2.0	2.3	1.1	3.0	2.1	2.9	0.6	0.2	14.3	0.4	2.3	0.3	1.7	2.4	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5	148.9	104.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	58.0	31.4	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	7.1	2.9	0.0	0.0	5.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	14.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330318-74398473	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.6"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		64000	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	3.0	4.0	30.6	4.9	19.8	4.0	3.2	6.3	48.6	6.1	4.5	1.3	1.0	2.3	6.1	1.9	2.1	4.7	4.8	1.6	30.1	15.1	2.5	2.1	2.7	4.0	9.7	20.4	1.7	4.4	1.4	4.5	2.1	11.7	3.8	5.1	2.9	3.2	2.5	7.1	1.7	2.6	5.6	2.6	2.5	3.4	2.3	0.3	10.0	4.1	1.3	4.0	5.2	2.6	2.4	1.7	2.5	0.6	3.0	7.5	1.1	2.1	3.0	11.8	2.1	3.6	1.6	0.3	2.8	2.1	2.4	2.7	1.1	5.5	0.2	7.0	1.8	4.3	1.0	2.3	0.5	2.3	0.8	1.2	1.6	1.6	0.9	0.4	1.9	2.6	0.8	0.5	5.5	1.0	2.7	13.4	4.0	2.1	1.5	16.0	0.3	7.6	1.7	2.3	1.6	2.7	2.4	15.4	0.1	6.4	0.4	0.5	2.3	4.5	1.0	2.0	3.4	0.2	0.3	11.1	5.5	5.1	2.2	2.9	2.0	2.9	0.2	0.5	2.7	1.3	2.5	0.6	1.1	2.1	0.6	2.8	2.4	3.5	2.3	0.5	1.8	3.3	1.9	0.7	3.0	0.3	1.7	7.5	1.1	30.6	19.8	6.3	24.4	30.1	15.1	9.7	20.4	11.7	0.3	6.0	5.4	13.7	35.5	6.8	10.1	6.1	12.7	76.3	30.7	8.7	15.7	0.6	5.0	31.7	9.2	20.2	5.3	70.0	109.6	4.7	15.4	55.2	8.1	0.9	4.8	7.9	11.3	20.3	20.4	2.3	2.3	14.4	15.1	3.6	15.9	5.0	102.3	7.0	3.5	3.3	9.9	25.8	11.3	17.6	14.5	4.5	0.1	17.0	18.7	42.9
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 66.2;Hepatocytes: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 26.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	26.6	4.3	1.2	3.2	3.4	4.4	21.4	0.8	1.7	19.7	8.3	1.5	10.3	1.9	22.8	11.0	12.8	6.5	4.3	17.3	1.5	1.4	4.7	58.5	7.8	6.9	3.3	1.0	16.2	4.1	40.7	2.4	18.7	4.7	25.3	4.0	3.3	12.9	15.5	34.8	6.7	4.5	33.7	5.1	5.4	6.3	8.6	2.8	1.6	11.5	6.8	4.5	37.0	21.7	0.8	0.8	25.3	0.7	0.9	1.5	0.6	3.6	1.4	4.1	1.4	10.3	8.8	14.9	1.3	4.4	1.6	2.0	5.5	1.7	1.3	2.2	2.7	9.1	0.6	0.7	1.0	1.7	3.9	0.6	2.2	0.6	0.0	4.6	1.1	9.7	7.2	3.3	1.4	8.3	12.5	26.3	6.5	1.6	3.1	0.6	2.2	5.9	2.0	5.9	8.2	1.2	2.4	5.2	2.2	16.0	14.8	0.0	7.7	2.4	0.1	10.3	6.9	1.9	2.2	18.2	4.8	1.6	0.9	1.7	1.7	3.9	0.0	8.4	3.4	1.4	18.0	0.7	7.4	1.1	0.6	0.9	0.8	1.0	0.6	0.4	0.7	1.5	0.7	25.3	0.9	0.3	0.8	0.7	0.6	1.2	3.4	0.8	1.7	1.5	1.4	3.3	1.0	4.7	2.8	11.9	34.6	3.0	17.9	9.5	3.4	66.2	35.7	48.2	30.7	8.7	5.9	10.1	3.3	8.3	10.4	20.6	8.4	0.0	11.2	25.5	12.1	10.8	32.4	135.4	6.1	6.4	0.0	32.5	10.8	2.7	8.9	13.6	5.0	1.0	8.9	3.5	13.2	3.5	17.0	5.3	13.5	12.9	15.5	1.9	4.7	10.7	15.3	6.4	4.7	1.6
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 213.5;Hepatocytes: 61.4;Muller glia cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4;HHSteC: 20.8;hTERT-RPE1: 33.7;LHCN-M2: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA					"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	10.4	4.7	2.2	0.0	11.4	8.9	4.7	5.1	0.0	0.8	0.0	0.4	10.7	1.9	0.6	0.2	1.2	8.7	0.0	0.0	0.1	16.4	1.8	20.8	0.0	0.0	7.6	2.0	3.0	0.1	33.7	1.1	0.0	5.3	0.0	39.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.4	10.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.7	7.8	2.1	2.1	2.7	1.6	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1	0.0	0.0	0.0	10.2	4.0	8.9	213.5	0.0	0.0	0.0	3.5	0.0	0.1	6.6	1.7	0.0	3.5	0.0	0.0	10.2	0.2	6.6	3.2	0.0	61.4	1.1	17.5	9.7	1.8	2.4	0.0	2.6	0.0	11.8	0.0	0.0	120.0	6.4	0.0	7.1	1.6	12.5	0.0	21.7	0.2	1.4	3.4	0.2	0.0	0.0	0.9
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7;SK-MEL-30: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		16000000	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.3	38.3	6.9	6.7	17.7	33.4	5.1	10.8	14.2	9.1	7.7	8.6	6.6	6.3	12.8	14.4	17.1	21.5	7.8	28.8	5.0	3.5	4.8	5.1	3.1	14.7	21.0	7.5	7.1	19.4	27.0	23.1	34.3	11.3	11.6	4.0	2.7	16.1	12.7	14.8	7.5	5.8	6.2	6.5	71.7	5.7	12.6	8.4	49.9	9.8	10.4	6.5	7.4	13.0	89.9	5.7	9.1	4.8	25.5	10.8	6.6	11.5	22.0	6.2	9.6	2.4	12.1	5.9	58.7	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4	8.9	28.8	2.2	18.7	10.5	23.6	93.8	15.3	9.4	9.1	24.4	35.3	5.9	10.0	15.4	2.4	10.8	83.8	0.0	14.5	5.7	9.1	20.1	5.8	5.9	10.0	17.5	27.1	8.6	15.2	6.8	25.3	11.0	33.7	18.0	47.4	20.4	19.1	57.9	81.3	9.9	9.4	0.0	17.6	1.7	4.9	8.8	3.7	12.8	52.1	7.1
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 57.0;HMC-1: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.7	8.1	2.1	13.4	10.0	12.0	23.4	5.8	4.9	16.0	24.4	21.4	3.7	0.0	11.3	34.4	19.0	57.0	21.7	29.2	27.8	0.1	9.2	5.5	13.0	16.6	17.9	20.9	63.0	25.5	11.9	21.6	9.1	15.9	14.1	0.1	2.2	0.1	11.3	28.7	0.0	28.9	8.1	2.6	30.2	0.5	7.5	1.1	22.1	19.3	0.9	0.9	26.3	9.1	0.3	8.5	4.3	41.1	0.6	6.2	10.4	11.5	18.6	0.2	0.0	0.0	5.7	21.7	3.3	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4	20.8	7.5	2.7	8.9	27.2	4.1	2.0	7.6	10.7	15.9	7.0	0.0	29.4	3.3	9.4	0.4	6.0	3.4	0.0	1.8	117.8	14.4	8.6	5.8	53.3	137.9	1.6	1.2	6.7	43.8	0.7	13.3	29.1	18.6	15.4	6.9	253.1	7.2	0.0	20.5	3.4	9.1	6.5	7.1	0.7	0.6	19.4	17.6	2.9	11.5	7.4
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 46.7;Late spermatids: 32.1;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.3;NB-4: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		12000000			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.4	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.8	0.8	0.3	8.3	0.6	0.6	0.2	0.1	0.0	2.4	1.5	1.5	0.0	2.2	1.5	4.8	1.7	0.2	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	1.1	0.7	0.9	0.6	0.0	0.9	0.4	0.1	2.4	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8	0.0	2.9	0.0	0.6	0.7	3.6	46.7	0.0	0.0	1.2	0.0	3.9	0.5	0.0	0.1	11.7	1.0	0.7	0.0	0.0	0.2	2.1	0.4	0.0	0.0	0.4	0.0	0.0	1.8	1.2	32.1	15.3	0.9	0.0	0.0	0.7	9.1	0.2	0.0	41.4	0.0	1.2	6.5	15.3	1.0	0.9	0.5	0.1	1.3	0.8	0.3
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	79.9	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	29.8	0.0
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 256.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 49.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.2	49.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3.0	1.0	1.5	0.2	0.0	12.5	0.3	63.7	0.0	0.0	40.1	9.8	0.0	53.0	18.3	10.9	0.0	32.7	0.0	12.6	0.0	0.2	1.4	0.0	2.8	0.1	20.6	0.0	0.6	0.0	3.3	1.1	0.0	0.0	2.8	3.8	1.6	3.4	7.2	0.4	256.0	11.9	0.0	0.1	0.7	0.3	0.1	0.1	0.0	8.0	0.5
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 652.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 132.2;SiHa: 134.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		210000000	"Plasma membrane"	Nucleoplasm	"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.4	69.3	7.1	22.0	8.6	6.9	65.6	28.6	11.0	15.0	13.3	66.2	31.2	18.1	31.8	16.8	28.7	57.0	12.9	56.2	8.0	32.9	12.2	13.0	50.5	29.2	79.9	15.2	19.0	15.1	132.2	18.3	56.1	5.5	8.7	39.4	25.0	40.1	9.2	79.2	15.6	19.4	11.8	20.5	23.5	16.2	10.7	35.4	10.5	9.2	12.1	5.8	134.7	50.5	97.2	12.0	18.1	19.9	16.0	15.3	22.8	22.4	20.1	49.9	55.3	57.4	15.0	23.9	43.6	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8	44.7	40.7	54.9	229.6	193.7	59.3	10.9	20.4	36.1	40.9	47.1	62.8	187.9	28.2	148.4	23.7	94.0	85.3	93.5	129.2	134.7	88.4	145.6	82.0	22.5	178.6	50.9	80.9	70.6	47.5	19.5	28.1	97.7	212.6	153.3	33.1	212.1	128.6	31.6	28.7	161.8	52.2	6.5	137.2	12.6	29.8	131.6	652.9	75.6	40.7	193.5
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Cell type enriched"	"Detected in some"	5	"Proximal tubular cells: 55.5"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	2.7	0.0	5.2	3.9	0.1	1.7	0.0	0.7	0.0	0.0	0.0	6.6	6.5	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	55.5	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 51.8"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 233.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;SK-MEL-30: 1.5;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039913, HPA042045"	Enhanced				"Intracellular and membrane"	NA	NA		12000000			"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	24.1	0.0	0.0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.1	0.1	51.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	5.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.2	0.9	1.8	0.3	1.5	0.1	0.7	0.0	0.8	0.1	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.1	37.2	0.0	2.9	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	233.7	2.0	0.0	0.0	0.0	0.9	0.0	0.6	5.8	1.8	16.5	0.0	0.0	0.1	1.8	0.8	0.0	0.0	0.0	1.2	0.0
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 85.7;Hep G2: 99.2;U-2197: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		42000	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.9	85.7	9.4	12.3	30.9	34.4	7.9	16.3	19.4	16.1	14.8	12.0	18.5	3.1	10.2	22.6	14.8	5.1	9.8	4.6	16.9	4.0	1.7	3.5	11.1	99.2	12.2	4.3	3.5	11.5	2.5	27.6	8.7	13.0	10.3	2.5	4.6	2.6	11.1	14.6	4.2	4.7	7.6	32.4	6.3	7.2	14.6	3.1	8.9	19.7	4.8	7.1	10.0	5.9	6.8	7.2	3.3	3.6	12.0	16.6	7.7	61.6	7.8	6.0	4.3	3.1	14.0	3.6	8.6	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8	23.8	22.2	19.5	56.0	103.1	7.7	7.3	22.9	72.3	30.7	19.2	13.7	18.5	59.7	44.3	0.9	20.2	111.9	0.0	293.1	59.3	101.2	100.0	35.7	215.1	16.1	9.5	108.6	23.4	18.5	0.9	30.8	17.2	28.7	26.2	69.3	5.2	205.5	85.2	27.3	54.9	8.6	32.3	92.4	2.4	4.0	35.0	24.3	11.5	88.0	69.0
